Mihael Polymeropoulos
Net worth: 10 M $ as of 31/05/2026
Net worth: 10 M $ as of 31/05/2026
Dr. Mihael H.
Polymeropoulos, MD, is a Chairman, President & Chief Executive Officer at Vanda Pharmaceuticals, Inc. Dr. Polymeropoulos was previously employed as a VP & Head-Pharmacogenetics Department by Novartis AG, a Chief-Gene Mapping Section by National Human Genome Research Institute, and a Co-Founder by Integrated Molecular Analysis of Genome Expression.
He received his undergraduate degree from the University of Patras.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/04/2026 | 1,588,246 ( 2.64% ) | 10 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| VANDA PHARMACEUTICALS INC. | Chief Executive Officer | 01/05/2003 |
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2003 |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Corporate Officer/Principal | 01/01/1998 |
Integrated Molecular Analysis of Genome Expression | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Vanda Pharmaceuticals, Inc.
Vanda Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company, which focuses on the development and commercialization of therapies | Health Technology |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Patras
University of Patras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Integrated Molecular Analysis of Genome Expression | |
National Human Genome Research Institute
National Human Genome Research Institute General GovernmentGovernment Engages in genetic and genomic research | Government |
Select your edition
All financial news and data tailored to specific country editions